Intrinsic Value of S&P & Nasdaq Contact Us

vTv Therapeutics Inc. VTVT

NASDAQ Capital Marke

SharesGrow Score
46/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$51.33
+36.1%

vTv Therapeutics Inc. (VTVT) current share price is $37.72. The gold spot price is $4,825.20 per troy ounce. Using the formula: VTVT in gold = $37.72 × 31.1035 ÷ $4,825.20 = 0.2431 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of VTVT when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding VTVT shares over the measured period.

VTVT in US Dollars
Gold in US Dollars
VTVT in Gold (grams per share)

Real Wealth Growth Rate

VTVT
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{VTVT}_{\text{gold}}(t) = \frac{P_{\text{VTVT}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{VTVT}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{VTVT}_{\text{gold}}^{(T)}}{\text{VTVT}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{VTVT}_\text{gold}^{(0)}$ = initial gold-price, $\text{VTVT}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

ERAS
ERAS
Erasca, Inc.
$18.20
+1.96%
EWTX
EWTX
Edgewise Therapeutics, Inc.
$33.70
+1.63%
IMMX
IMMX
Immix Biopharma, Inc.
$10.04
+1.93%
ZURA
ZURA
Zura Bio Limited
$5.69
-0.52%
CCCC
CCCC
C4 Therapeutics, Inc.
$2.89
+4.90%
PYXS
PYXS
Pyxis Oncology, Inc.
$1.71
+0.59%
SGTX
SGTX
Sigilon Therapeutics, Inc.
$22.47
-2.56%
KRON
KRON
Kronos Bio, Inc.
$0.88
+1.49%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message